Tweet by Michael Okun on Twitter. Alzheimer’s drug Posted byJoseph Thornton MDSeptember 27, 2022Posted inBlog Michael Okun @MichaelOkun Huge Alzheimer’s news; new drug! Phase 3 confirmatory Clarity AD clinical trial of lecanemab, investigational anti-amyloid beta (Aβ) protofibril antibody, met primary endpoint (CDR-SB: Clinical Dementia Rating-Sum of Boxes) and key secondary endpoints. Great news! @FixelInstitute pic.twitter.com/vYSKJy9MX3 9/27/22, 8:47 PM Joseph Thornton Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related Published by Joseph Thornton MD Teacher, Clinical Supervisor Clinical Associate Professor, Psychiatry University of Florida Affiliation is for identification only. All content and opinions are my own. View more posts
Gator Psychiatry 